Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGraft Polymer Regulatory News (GPL)

Share Price Information for Graft Polymer (GPL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.145
Bid: 0.14
Ask: 0.15
Change: 0.00 (0.00%)
Spread: 0.01 (7.143%)
Open: 0.145
High: 0.145
Low: 0.145
Prev. Close: 0.145
GPL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Corporate Presentation

20 Mar 2023 07:00

RNS Number : 4426T
Graft Polymer (UK) PLC
20 March 2023
 

20 March 2023

Graft Polymer (UK) Plc

 

("Graft Polymer", the "Company", and together with its subsidiaries, the "Group")

 

New Corporate Presentation   

Graft Polymer (UK) Plc (LSE: GPL), a business focused on the development and commercial production of polymer modification, biological supplements, and nano-drug delivery systems, is pleased to announce that an updated corporate presentation is now available on its website: https://graftpolymer.com/.

**ENDS**

 

For more information, please visit    https://www.graftpolymer.com   or contact:

 

Graft Polymer (UK) Plc

via St Brides Partners

Roby Zomer, Chairman

Yifat Steuer, CFO

Turner Pope Investments (Broker)

+44 20 3657 0050

James Pope

Andy Thacker

St Brides Partners (Public Relations)

Catherine Leftley

graftpolymer@stbridespartners.co.uk

Ana Ribeiro

Max Bennett

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAJLMRTMTABBTJ
12
Date   Source Headline
9th May 20247:00 amRNSUpdate on recent developments
7th May 20247:00 amRNSGrant of Haemostatic Hydrogel Patent
3rd May 20247:00 amRNSDivestment of Graft Polymer d.o.o – Slo facility
2nd May 20247:00 amRNSReplacement of Chief Executive Officer
30th Apr 20245:05 pmRNSAnnual Financial Report
23rd Apr 20244:17 pmRNSLoan facility update
15th Mar 20247:00 amRNSChairman & Directorate Change & Financial Update
8th Jan 20245:00 pmRNSHolding(s) in Company
8th Jan 20245:00 pmRNSGM Statement
8th Jan 20245:00 pmRNSHolding(s) in Company
8th Jan 20245:00 pmRNSHolding(s) in Company
8th Jan 20245:00 pmRNSHolding(s) in Company
8th Jan 20245:00 pmRNSHolding(s) in Company
8th Jan 20245:00 pmRNSDirector/PDMR Shareholding
27th Dec 20237:00 amRNSGM Notice 8th January 2024
22nd Dec 20237:00 amRNSPlacing of New Ordinary Shares
9th Oct 20237:00 amRNSPivotal Agreement within European Consortium
27th Sep 20237:02 amRNSUpdated Investor Presentation
27th Sep 20237:00 amRNSInterim Financial Results
11th Sep 20237:00 amRNSR&D Agreement with Slovenian Faculty
4th Sep 20237:00 amRNSR&D and supply agreement with FORPET BALTIC
30th Aug 20237:00 amRNSR&D Supply Agreement Signed
23rd Aug 20237:00 amRNSGraft Bio signs manufacturing services agreement
27th Jul 202311:54 amRNSResult of AGM
26th Jul 20237:00 amRNSDistribution agreement with US Inter-Technologies
6th Jul 20237:00 amRNSNew R&D and Supply Agreement with Gabriel Chemie
5th Jul 20237:00 amRNSOperational Update
4th Jul 20237:00 amRNSAGM Notice
16th May 20232:08 pmRNSDirector Share Purchase
27th Apr 20237:00 amRNSFinal Results
21st Mar 20237:00 amRNSGraftBio - MGC Pharma Update
20th Mar 20237:00 amRNSCorporate Presentation
9th Feb 20237:00 amRNSUpdate: New Product Lines & Facility Expansion
30th Sep 20227:00 amRNSInterim Results
20th Sep 20227:00 amRNSNew Corporate Presentation
18th Aug 202210:00 amRNSFirst Commercial Purchase Order for GraftBio
28th Jul 202212:30 pmRNSResult of AGM
4th Jul 20224:50 pmRNSNotice of AGM
29th Jun 20227:00 amRNSFinal Results
20th Jun 20227:00 amRNSOperational Update
17th Jun 20227:00 amRNSGraftBio IP – MGC Pharma Update
18th May 20227:00 amRNSDirector Share Purchase
12th May 20227:00 amRNSHACCP Certificate Enabling Access to B2C Market
22nd Apr 20227:17 amRNSGrant of patents
7th Apr 20227:00 amRNSPre-payment for equipment
6th Apr 202211:50 amRNSDirector/PDMR Shareholding
21st Feb 20227:00 amRNSUpdate on Operations
15th Feb 20227:00 amRNSChange of Year End
25th Jan 20227:00 amRNSBusiness Update
11th Jan 20227:00 amRNSInvestor Presentation
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.